Physician profile
Benjamin James Farley
NPI 1548899222
$20,659.57
in general payments reported to CMS, 2019-2025
12 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $19K · Food and Beverage: $1,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $18,750.00 |
| Food and Beverage | $1,909.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2025 | |
| Acumed LLC | $7,500.00 | 2025 | |
| Smith+Nephew, INC. | $1,250.00 | 2025 | |
| Stryker Corporation | $722.83 | 2025 | Mako, 7 X 23mm Citrelock Implant, Citrefix |
| Peerless Surgical INC. | $402.94 | 2025 | |
| Supreme Orthopedic Systems, LLC | $163.36 | 2025 | |
| Depuy Synthes Sales INC. | $156.17 | 2025 | Hammerlock, Motoband, Na |
| Sanara Medtech INC. | $150.80 | 2025 | Biasurge |
| Medtronic, INC. | $121.20 | 2025 | Unid_pass |
| Orthofix Medical, INC. | $86.89 | 2025 | Physio-Stim |
| Alafair Biosciences, INC. | $75.90 | 2025 | Versawrap |
| Vericel Corporation | $29.48 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Farley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.